Additionally, it might be possible to develop inhibitors of the SPOC-NCoR/SMRT interaction to block the repressive activity of SHARP and reactivating the Notch pathway in those tumors in which Notch acts as a tumor suppressor. Here, SPEN is linked to neoplasm.